Covered recipient · General Payments record
SUZIE MARTIKYAN
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2023–2024
$1,240.22
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $617.11 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Koya Medical, Inc. | $146.85 | 1 |
| Amgen Inc. | $121.58 | 1 |
| Bioventus LLC | $69.50 | 3 |
| BIOTISSUE HOLDINGS INC. | $64.89 | 3 |
| ABBVIE INC. | $40.08 | 2 |
| ORGANOGENESIS INC. | $38.71 | 2 |
| DePuy Synthes Sales Inc. | $38.38 | 1 |
| Kerecis Limited | $35.16 | 1 |
| Paratek Pharmaceuticals, Inc. | $22.07 | 1 |
| Curonix LLC | $21.45 | 1 |
| Integra LifeSciences Corporation | $18.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.10 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972293 | CMS |
| ABBVIE INC. | $20.98 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972295 | CMS |
| Amgen Inc. | $121.58 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115905030 | CMS |
| BIOTISSUE HOLDINGS INC. | $25.69 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148779939 | CMS |
| BIOTISSUE HOLDINGS INC. | $19.60 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148751268 | CMS |
| BIOTISSUE HOLDINGS INC. | $19.60 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148761905 | CMS |
| Bioventus LLC | $25.64 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137444766 | CMS |
| Bioventus LLC | $21.89 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137444768 | CMS |
| Bioventus LLC | $21.97 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137444770 | CMS |
| Curonix LLC | $21.45 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132909923 | CMS |
| DePuy Synthes Sales Inc. | $38.38 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077814170 | CMS |
| Integra LifeSciences Corporation | $18.44 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140136783 | CMS |
| Kerecis Limited | $35.16 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120109131 | CMS |
| Koya Medical, Inc. | $146.85 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154349317 | CMS |
| Organogenesis Inc. | $15.63 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145437687 | CMS |
| Organogenesis Inc. | $23.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145437689 | CMS |
| Paratek Pharmaceuticals, Inc. | $22.07 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113909374 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.